BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Breast Cancer
,
Endothelial cell
,
Alcohol
,
Tamoxifen
,
PDX1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
myelomas
Summary
General Info
Curated Studies
Most Correlated Studies
MMRC expression reference collection of newly diagnosed and relapsed multiple myeloma patients
Resistance to RNA-directed nucleoside analogues in B-Cell neoplasms
Waldenströms macroglobulinemia gene expression profiles
Multiple myeloma cells with WT, mutant or null p53 status treated with PRIMA-1Met
Bone marrow expression profiles evolving steps of monoclonal gammopathies
Explore Curated Studies Results
Literature
Most Relevant Literature
Determining optimal combination regimens for patients with multiple myeloma.
MonumenTAL Results for Talquetamab in Myeloma.
Refractory multiple myeloma: Count refractory drugs, not lines of treatment
Trial designs and endpoints for immune therapies in multiple myeloma.
Management of multiple myeloma-related renal impairment: recommendations from the International Myel…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarkers in Multiple Myeloma
CTFEA Myeloma Study
Oligosecretary Myeloma: Prevalence and Its Clinical Significance
Machine Learning in Myeloma Response
A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ